Community-based outbreaks in vulnerable populations of invasive infections caused by streptococcus pneumoniae serotypes 5 and 8 in calgary, Canada

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  vanderkooi, Otto G ^a,b,c   Church, Deirdre L ^a,c   MacDonald, Judy ^a,d   Zucol, Franziska ^b   Kellner, James D ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b ALBERTA CHILDREN'S HOSPITAL   (Canada)

^c CALGARY LABORATORY SERVICES   (Canada)

^d ALBERTA HEALTH SERVICES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; COTRIMOXAZOLE; ERYTHROMYCIN; ILLICIT DRUG; PENICILLIN G; SULFADOXINE; TRIMETHOPRIM; TRIMETHOPRIM, SULFADOXINE DRUG COMBINATION;

ABORIGINE; ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ASTHMA; BACTERIUM ISOLATE; CANADA; CLONAL VARIATION; COMMUNITY LIVING; CONTROLLED STUDY; EPIDEMIC; FEMALE; GENETIC VARIABILITY; HIGH RISK POPULATION; HOMELESSNESS; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOLECULAR PHYLOGENY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHENOTYPIC VARIATION; PNEUMOCOCCAL INFECTION; REVIEW; SEROTYPE; SMOKING; STREPTOCOCCUS PNEUMONIAE; ARTICLE; CLASSIFICATION; DRUG COMBINATION; DRUG EFFECT; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PATHOGENICITY;

ALBERTA; DISEASE OUTBREAKS; DRUG COMBINATIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; SULFADOXINE; TRIMETHOPRIM;

EID: 84455161879     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028547     Document Type: Review

References (35)

1. DeMaria A Jr, Browne K, Berk SL, Sherwood EJ, McCabe WR, (1980) An outbreak of type 1 pneumococcal pneumonia in a men's shelter. JAMA 244: 1446.
2. Fiore AE, Iverson C, Messmer T, Erdman D, Lett SM, et al. (1998) Outbreak of pneumonia in a long-term care facility: antecedent human parainfluenza virus 1 infection may predispose to bacterial pneumonia. J Am Geriatr Soc 46: 1112.
3. Gleich S, Morad Y, Echague R, Miller JR, Kornblum J, et al. (2000) Streptococcus pneumoniae serotype 4 outbreak in a home for the aged: report and review of recent outbreaks. Infect Control Hosp Epidemiol 21: 711.
4. Hoge CW, Reichler MR, Dominguez EA, Bremer JC, Mastro TD, et al. (1994) An epidemic of pneumococcal disease in an overcrowded, inadequately ventilated jail. N Engl J Med 331: 643-648.
5. Nuorti JP, Butler JC, Crutcher JM, Guevara R, Welch D, et al. (1998) An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents. N Engl J Med 338: 1861.
6. Sanchez JL, Craig SC, Kolavic S, Hastings D, Alsip BJ, et al. (2003) An outbreak of pneumococcal pneumonia among military personnel at high risk: control by low-dose azithromycin postexposure chemoprophylaxis. Mil Med 168: 1-6.
7. Cherian T, Steinhoff MC, Harrison LH, Rohn D, McDougal LK, et al. (1994) A cluster of invasive pneumococcal disease in young children in child care. JAMA 271: 695-697.
8. Hausdorff WP, Feikin DR, Klugman KP, (2005) Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis 5: 83-93.
9. Twele LGTG, Vanderkooi OG, Macdonald J, Church D, Scheifele D, Kellner JD, (2005) Large Outbreak of Serotype 5 Invasive Pneumococcal Disease in Predominantly Homeless Persons in Calgary, Canada; 2007 September 2007; Chicago, IL, USA.
10. Kellner JD, (2006) Outbreaks of serotypes 5 and serotype 8 invasive pneumococcal disease in Calgary, Alberta, Canada. Archive number 20061214.3520.: ProMED-mail.
11. Lovgren M, Tyrrell G, Kellner JD, Hoang L, Horsman G, et al. (2008) Outbreak of Streptococcus pneumoniae Serotype 5 in Western Canada. Alberta Provincial Laboratory of Public Health Scientific Symposium. Edmonton, AB, Canada.
12. Tyrrell GJLM, Kellner JD, Grimsrud K, Hoang L, Patrick D, Horsman G, et al. (2008) The Serotype 5 Invasive Pneumococcal Investigation Team. A Large Outbreak of Invasive Streptococcus pneumoniae Serotype 5 in Western Canada; 2008 June 2008; Reykjavik, Iceland.
13. Romney MG, Hull MW, Gustafson R, Sandhu J, Champagne S, et al. (2008) Large community outbreak of Streptococcus pneumoniae serotype 5 invasive infection in an impoverished, urban population. Clin Infect Dis 47: 768-774.
14. Kellner JD, Vanderkooi OG, MacDonald J, Church DL, Tyrrell GJ, et al. (2009) Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study. Clin Infect Dis 49: 205-212.
15. Clinical and Laboratory Standards Institute (2006) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 7th ed. Approved standard M7-A7. Clinical and Laboratory Standards Institute, Wayne, Pa.
16. Clinical and Laboratory Standards Institute (2006) Performance Standards for antimicrobial susceptibility testing. 16th Informational Supplement, M100-S16. Clinical and Laboratory Standards Institute, Wayne, Pa.
17. Clinical and Laboratory Standards Institute (2009) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 8th ed. Approved standard M07-A8. Clinical and Laboratory Standards Institute, Wayne, Pa 29.
18. Clinical and Laboratory Standards Institute (2009) Performance Standards for Antimicrobial Susceptibility Testing. M100-S19. Clinical and Laboratory Standards Institute, Wayne, Pa 29.
19. O'Brien KL, Nohynek H, (2003) Report from a WHO Working Group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae. Pediatr Infect Dis J 22: e1-11.
20. Enright MC, Spratt BG, (1998) A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144: 3049-3060.
21. Tamayo M, Sa-Leao R, Sanches IS, Castaneda E, de Lencastre H, (1999) Dissemination of a Chloramphenicol- and Tetracycline-Resistant but Penicillin-Susceptible Invasive Clone of Serotype 5 Streptococcus pneumoniae in Colombia. J Clin Microbiol 37: 2337-2342.
22. Pneumococcal Molecular Epidemiology Network (PMEN). (2006).
23. Firacative C, Moreno J, Rosales P, Maldonado A, Sanchez J, et al. (2009) Circulation of Streptococcus pneumoniae clone Colombia 5 ST289 in nine Latin American countries. Rev Panam Salud Publica 25: 337-343.
24. Wenger JD, Zulz T, Bruden D, Singleton R, Bruce MG, et al. (2009) Invasive Pneumococcal Disease in Alaskan Children: Impact of the Seven-Valent Pneumococcal Conjugate Vaccine and the Role of Water Supply. Pediatr Infect Dis J.
25. Plevneshi A, Svoboda T, Armstrong I, Tyrrell GJ, Miranda A, et al. (2009) Population-based surveillance for invasive pneumococcal disease in homeless adults in Toronto. PloS one 4: e7255.
26. Mercat A, Nguyen J, Dautzenberg B, (1991) An outbreak of pneumococcal pneumonia in two men's shelters. Chest 99: 147.
27. Stroick SM, Hubac L, Richter-Salomons S, (2008) Biennial Count of Homeless Persons in Calgary: 2008 May 14. In: Community and Neighbourhood Services SRU, editor. Calgary.
28. Foundation CH (2009) Calgary Triage and Assessment Survey. Calgary.
29. National Adivsory Committee on I (2008) Statement on the recommended use of pneumococcal 23-valent polysaccharide vaccine in homeless persons and injection drug users. An Advisory Committee Statement (ACS). Can Commun Dis Rep 34: 1-12.
30. Merck and Co, I (1986, 2007) Pneumovax 23 (Pneumococcal Vaccine Polyvalent)- product monograph.
31. Ansaldi F, Turello V, Lai P, Bastone G, De Luca S, et al. (2005) Effectiveness of a 23-valent polysaccharide vaccine in preventing pneumonia and non-invasive pneumococcal infection in elderly people: a large-scale retrospective cohort study. J Int Med Res 33: 490-500.
32. Prevnar, Pneumococcal 7-valent Conjugate Vaccine- Product Monograph. (2008), Wyeth Canada.
33. Shouval DS, Greenberg D, Givon-Lavi N, Porat N, Dagan R, (2009) Serotype coverage of invasive and mucosal pneumococcal disease in israeli children younger than 3 years by various pneumococcal conjugate vaccines. Pediatr Infect Dis J 28: 277-282.
34. Brueggemann AB, Peto TE, Crook DW, Butler JC, Kristinsson KG, et al. (2004) Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J Infect Dis 190: 1203-1211.
35. Kellner JD, Scheifele D, Vanderkooi OG, Macdonald J, Church DL, et al. (2008) Effects of routine infant vaccination with the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization with streptococcus pneumoniae in children in Calgary, Canada. Pediatr Infect Dis J 27: 526-532.